Phenotypic and Genotypic Detection of Biofilm Formation and Efflux Pump Activity in Multi-drug Resistant Klebsiella Pneumoniae
NCT07541690 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-21
Summary
1. Sample: urine, pus and sputum samples.
2. Culture: the samples will be inoculated on the MacConkey agar and subcultured on eosine methylene blue agar.
3. Identification of isolates will be done by:
* Colony morphology.
* Gram staining.
* Biochemical reactions: including Indole, Methyl red, Voges-Proskauer, and Citrate utilization (IMViC) tests.
4. Antimicrobial susceptibility testing of the isolates will be performed using the Kirby-Bauer method (disc diffusion method) using Muller Hinton agar according to the Clinical and Laboratory Standards Institute (CLSI 2025) guidelines for selected groups of antibiotics.
5. Phenotypic detection of biofilm formation by the microtitre plate method.
6. Phenotypic detection of efflux pump activity by ethidium bromide-agar cartwheel method.
7. Detection of biofilm genes (fimH-1, mrkA, and mrkD) by conventional PCR.
8. Detection of efflux pump genes (acrAB, tolC, and mdtk) by conventional PCR.
Conditions
- Multidrug Resistant Klebsiella Pneumoniae Infection
Interventions
- GENETIC
-
Genotypic Detection of Biofilm Formation and Efflux Pump Activity.
1. Phenotypic detection of biofilm formation by the microtitre plate method. 2. Phenotypic detection of efflux pump activity by ethidium bromide-agar cartwheel method. 3. Detection of biofilm genes (fimH-1, mrkA, and mrkD) by conventional PCR. 4. Detection of efflux pump genes (acrAB, tolC, and mdtk) by conventional PCR.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-08-31
- Completion
- 2027-02-28
More Related Trials
-
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
NCT04337840 ·Status: UNKNOWN
-
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT05181163 ·Status: UNKNOWN
-
Neutrophil Extracellular Traps (NETs) Mediated Killing of Carbapenem-resistant Pseudomonas Aeruginosa.
NCT06441708 ·Status: NOT_YET_RECRUITING
-
The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms
NCT04927806 ·Status: COMPLETED ·Phase: NA
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
NCT00518661 ·Status: COMPLETED
-
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
NCT03767283 ·Status: UNKNOWN
-
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
NCT00177957 ·Status: COMPLETED
-
The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
NCT03950544 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
NCT05613322 ·Status: TERMINATED
-
Phenotypic and Genotypic Detection of Colistin Resistance
NCT07487116 ·Status: NOT_YET_RECRUITING
-
Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae Infection
NCT06190548 ·Status: COMPLETED
-
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
NCT05239312 ·Status: UNKNOWN
-
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
NCT05017766 ·Status: RECRUITING
-
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
NCT06641778 ·Status: RECRUITING ·Phase: NA
-
Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated From Patients With Hospital Acquired Infections in Sohag University Hospitals, Egypt
NCT06628076 ·Status: COMPLETED
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Comparison of Epithelial Lining Fluid and Blood Pharmacokinetics and Pharmacodynamics of Intravenous and Intravenous Plus Nebulized Polymyxin B in Multidrug Resistant Bacteria Ventilator-associated Pneumonia Patients
NCT06076603 ·Status: RECRUITING
-
Epidemiology of Klebsiella Pneumoniae in China
NCT03598543 ·Status: UNKNOWN
-
Development of a Probiotic Strategy to Prevent or Eliminate Nasal Colonization With S. Aureus
NCT00977496 ·Status: WITHDRAWN
-
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
NCT00037050 ·Status: COMPLETED ·Phase: PHASE3
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01426191 ·Status: COMPLETED